Physician profile
Matthew B Schumer
NPI 1912952250
$777.36
in general payments reported to CMS, 2019-2025
18 companies · $34.99 in 2025
The $34.99 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $103 · 2021: $20.03 · 2022: $138 · 2024: $216 · 2025: $34.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $251.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $158.18 | 2024 | |
| Abbvie INC. | $137.77 | 2022 | |
| Organogenesis INC. | $60.87 | 2019 | |
| Kci USA, INC. | $58.37 | 2019-2020 | |
| Solventum Corporation | $57.87 | 2024 | V.A.C. Veraflo, 3m Skin and Nasal Antiseptic, Activ.A.C. |
| Integra Lifesciences Corporation | $42.50 | 2019-2020 | |
| Smith+Nephew, INC. | $38.31 | 2021-2025 | Collagenase Santyl |
| Amgen INC. | $33.54 | 2019 | |
| Allergan, INC. | $33.24 | 2019-2020 | |
| Pfizer INC. | $32.85 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.80 | 2019 | |
| Ovik Health, LLC | $18.17 | 2020 | |
| Normatec Industries, Lp | $18.10 | 2020 | |
| Reprise Biomedical, INC. | $16.71 | 2025 | Miro3d |
| Ironshore Pharmaceuticals INC. | $13.69 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $13.68 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.08 | 2020 | |
| Aroa Biosurgery Incorporated | $11.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Schumer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.